ACOTEC-B(06669): The registration application of the heart valve balloon dilatation catheter RUNFLOW has been approved by the China National Medical Products Administration.

ACOTEC-B (06669) announced that the board of directors is pleased to announce that on September 19, 2024, the group received approval from the China National Medical Products Administration for the registration of the heart valve balloon dilation catheter RunFlow. RunFlow is used in the transcatheter aortic valve replacement (TAVR) procedure for the autologous valve dilation of the aorta. The product features an eight-balloon cavity design that allows smooth blood flow even when the balloon is fully inflated, effectively enhancing the safety and simplifying the operation of the surgery. The company will launch marketing activities in China at the appropriate time.